Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum CVR Medical Corp V.CVM.H

Alternate Symbol(s):  CRRVF

CVR Medical Corp. is a medical technology organization. The Company is focused on the development and advancement of technology at work within the healthcare sector. The Company’s Carotid Stenotic Scan (CSS) is a diagnostic tool designed to detect and determine a level of carotid narrowing for the purpose of identifying patients at risk for Ischemic Stroke. The CSS provides a synergistic tool... see more

TSXV:CVM.H - Post Discussion

CVR Medical Corp > My Biggest Concern
View:
Post by OleMule on Jun 29, 2020 4:30pm

My Biggest Concern

So I am not trying to start any rumours or panic, but my biggest concern is CVR Med will declare a reverse stock split prior to announcing a deal with Global and then we will all get crushed with the dilution. At least the former execs and directors were cognizant if dilution and were planning a milestone based funding approach.  I'm hearing maybe some dissent amongst the ranks at Global.  Time will tell, be patient, let's see what we can glean when the financials are filed. Maybe I'm totally off base and they have had a come to Jesus meeting. We shall see.
Comment by Hawkeye14 on Jul 03, 2020 6:37pm
I agree 100%. I now own 1/5 the number of shares that I owned after they took over from BBK and they are worth as much then as thet are now or less.
Comment by Looneytunes on Jul 05, 2020 3:53am
At the end of the day my wish is for the BOD to grow the share price, I'm not too worried about maintaining my ownership of a (minuscule) part of the company, As long as dilution and any funds raised through it are used to add value ( and therefore grow the sp ) then I'm OK with it. What I don't want to see is dilution to raise funds just to pay off some fictitious loan amounts the ...more  
Comment by Nastro on Jul 06, 2020 1:11pm
Their chief priority appears to be making sure that Bakema gets paid what he is 'owed' before advancing the prospects of the company.  Until this changes it's dead in the water.
Comment by EMTguy10 on Jul 06, 2020 8:06pm
I agree !!! 
Comment by XTRMNVSTR on Jul 08, 2020 9:57am
My biggest concern is we have not been operating properly for a while now and this thing won't get back up and going the way it should have been going and because of time we lose out on Canon, Hitachi, all the Trials etc. 
Comment by EMTguy10 on Jul 09, 2020 9:42am
Absolutely correct !!! Maybe these smart guys will realize this !! Or they just want there money back, lol. 
Comment by oldtimer42 on Jul 05, 2020 9:17pm
I agree with OleMule, a reverse split is in the cards. They need to get the SP up for any chance at financing. It could be as high as 5 to 1 to give management room for the dilution and encourage investors. I certainly hope it is not that high . On another note, the website is being updated. A sign of progress I guess. I wonder if the hospitals in the clinical trials are still on board.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities